Lindbrook Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-176
Closed -$2.09K 2791
2024
Q4
$2.09K Sell
176
-58
-25% -$989 ﹤0.01% 2293
2024
Q3
$6.48K Buy
234
+41
+21% +$1.03K ﹤0.01% 1899
2024
Q2
$4.6K Buy
193
+17
+10% +$399 ﹤0.01% 2037
2024
Q1
$3.1K Hold
176
﹤0.01% 2089
2023
Q4
$2.78K Sell
176
-562
-76% -$5.8K ﹤0.01% 2155
2023
Q3
$6.35K Buy
+738
New +$5.24K ﹤0.01% 1659
2023
Q1
Sell
-17
Closed -$200 2784
2022
Q4
$200 Sell
17
-14
-45% -$160 ﹤0.01% 2726
2022
Q3
$0 Buy
31
+16
+107% +$194 ﹤0.01% 2613
2022
Q2
$0 Buy
+15
New +$303 ﹤0.01% 2478

Other funds holding ASPN

Lindbrook Capital's ASPN Position: Q1 2025 in Review

Lindbrook Capital sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 176 shares — an estimated $2.09K sold.

Lindbrook Capital first reported a position in ASPN in Q2 2022 and held it in 9 quarters. The position peaked at $6.48K in Q3 2024. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Lindbrook Capital reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 176 Aspen Aerogels shares in Q1 2025, an estimated $2.09K.
  • Lindbrook Capital first reported a position in Aspen Aerogels in Q2 2022 and held it in 9 quarters.
  • Lindbrook Capital's Aspen Aerogels position peaked at $6.48K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.